Astrazeneca (AZN) Return on Sales [ROS] (2009 - 2026)
Astrazeneca (AZN) posted Return on Sales [ROS] of 29.12% for Q3 2026, up 4.18 percentage points from 24.94% a year earlier and up 8.55 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Astrazeneca was 24.88%, up 1.64 percentage points year-over-year; for FY2025, it was 23.40%, up 4.90 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for four consecutive years, with a five-year change of +4.00 percentage points (FY2020 to FY2025).
- In prior years, Astrazeneca's Return on Sales [ROS] was 18.50% in FY2024 (+0.61 pp), 17.88% in FY2023 (+9.41 pp), 8.47% in FY2022 (+5.65 pp) and 2.82% in FY2021 (-16.57 pp).
- Quarterly Return on Sales [ROS] has run from a low of -2.54% in Q4 2021 to a high of 29.51% in Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in seven of the last eight quarters, with an average year-over-year change of +3.21 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2022, with a gain of 28.52 percentage points; the weakest was Q4 2021, with a drop of 23.75 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 20.57% (Q2 2026), 29.51% (Q1 2026) and 20.48% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 32.98% |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.12% |
| Jun 30, 2026 | 20.57% |
| Mar 31, 2026 | 29.51% |
| Dec 31, 2025 | 20.48% |
| Sep 30, 2025 | 24.94% |
| Jun 30, 2025 | 24.27% |
| Mar 31, 2025 | 28.54% |
| Dec 31, 2024 | 15.24% |
| Sep 30, 2024 | 16.27% |
| Jun 30, 2024 | 21.22% |
| Mar 31, 2024 | 25.58% |
| Dec 31, 2023 | 10.90% |
| Sep 30, 2023 | 17.73% |
| Jun 30, 2023 | 21.51% |
| Mar 31, 2023 | 24.12% |
| Dec 31, 2022 | 9.76% |
| Sep 30, 2022 | 11.34% |
| Jun 30, 2022 | 5.00% |
| Mar 31, 2022 | 7.71% |
| Dec 31, 2021 | -2.54% |
API Access
Astrazeneca Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();